Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ERASCA INC(ERAS) | 11,055,554 | 7,091,557 | -3,963,997 | 41,127 | 114,741 | 16.95% | +73,615 |
| VIR BIOTECHNOLOGY INC(VIR) | 12,916,663 | 12,916,663 | 0 | 77,887 | 115,733 | 17.09% | +37,846 |
| GENERATE BIOMEDICINES INC(GENB) | 0 | 1,944,426 | +1,944,426 | 0 | 24,305 | 3.59% | +24,305 |
| RAPPORT THERAPEUTICS INC(RAPP) | 3,728,738 | 3,728,738 | 0 | 113,130 | 116,672 | 17.23% | +3,542 |
| Q32 BIO INC(FIXX) | 320,482 | 320,482 | 0 | 1,064 | 2,057 | 0.30% | +993 |
| 10X GENOMICS INC(TXG) | 737,539 | 217,834 | -519,705 | 12,029 | 4,625 | 0.68% | -7,405 |
| BEAM THERAPEUTICS INC(BEAM) | 4,540,132 | 4,540,132 | 0 | 125,852 | 108,191 | 15.98% | -17,661 |
| LYELL IMMUNOPHARMA INC(LYEL) | 2,759,072 | 3,247,162 | +488,090 | 84,924 | 65,138 | 9.62% | -19,786 |
| GOSSAMER BIO INC(GOSS) | 8,055,916 | 8,055,916 | 0 | 24,973 | 2,646 | 0.39% | -22,327 |
| MAZE THERAPEUTICS INC(MAZE) | 4,120,053 | 4,120,053 | 0 | 170,694 | 122,984 | 18.16% | -47,710 |